Marble Harbor Investment Counsel’s Novartis NVS Stock Holding History

Marble Harbor Investment Counsel’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-2,539	Closed	-$219K	–	151
2019 Q1	$219K	Buy	+2,539	New	+$204K	0.04%	138
2018 Q2	–	Sell	-2,985	Closed	-$216K	–	155
2018 Q1	$216K	Hold	2,985	–	–	0.04%	147
2017 Q4	$225K	Hold	2,985	–	–	0.04%	151
2017 Q3	$230K	Buy	+2,985	New	+$225K	0.05%	153
2015 Q1	–	Sell	-2,543	Closed	-$211K	–	139
2014 Q4	$211K	Hold	2,543	–	–	0.05%	143
2014 Q3	$215K	Hold	2,543	–	–	0.05%	136
2014 Q2	$206K	Buy	+2,543	New	+$200K	0.05%	140

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Marble Harbor Investment Counsel's NVS Position: Q2 2019 in Review

Marble Harbor Investment Counsel sold out of Novartis (NVS) in Q2 2019, closing a stake of 2,539 shares — an estimated $219K sold.

Marble Harbor Investment Counsel first reported a position in NVS in Q2 2014 and held it in 7 quarters. The position peaked at $230K in Q3 2017. 1,094 funds tracked by Wall St. Rank hold NVS as of Q2 2019.

Marble Harbor Investment Counsel reported no remaining Novartis position as of Q2 2019 after selling out during the quarter.
Marble Harbor Investment Counsel sold 2,539 Novartis shares in Q2 2019, an estimated $219K.
Marble Harbor Investment Counsel first reported a position in Novartis in Q2 2014 and held it in 7 quarters.
Marble Harbor Investment Counsel's Novartis position peaked at $230K in Q3 2017.
1,094 funds tracked by Wall St. Rank held Novartis as of Q2 2019.

Based on Marble Harbor Investment Counsel's 13F filing for Q2 2019, filed 7 Aug 2019.